Further, Mettl3 is also related to the chemosensitivity of cisplatin, and it might be possible to determine the chemotherapeutic dose of cisplatin by detecting the expression of Mettl3 in patients’ tumor tissues (Li et al., 2021a). This evidence concerns the gene METTL3 and neoplasm.